A late-stage trial of Cerevel Therapeutic’s Parkinson’s disease drug showed a significant reduction in the time patients suffer from symptoms, the company said Thursday, the latest study indicating ...
From advanced surgical options to next-generation medications and cell-based therapies, researchers are closer than ever to ...
The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to treat Parkinson's disease, Amneal Pharmaceuticals announced Wednesday. The treatment is a ...
An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug prospect that ...
A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...
Add Yahoo as a preferred source to see more of our stories on Google. Symptoms of Parkinson’s disease, such as tremors and stiffness, can make daily tasks difficult. A new drug has shown promise in ...
FILE PHOTO: Test tubes are seen in front of a displayed Abbvie logo in this illustration (Reuters) -AbbVie's drug met the main goal in a late-stage trial when tested in patients with early Parkinson's ...
Mouse models of GBA1 Parkinson’s disease that are treated with Gain Therapeutics’ clinical-stage drug appear to have better cognitive function and lower disease biomarkers than untreated animals. The ...
Hosted on MSN
Pseudoparkinsonism symptoms and their treatment
Antipsychotic drugs, antiemetics, and some antibiotics can cause pseudoparkinsonism. Doctors use symptoms, medical history, and neurological exams to diagnose pseudoparkinsonism. Pseudoparkinsonism ...
June 26 -- WEDNESDAY, June 25 (HealthDay News) -- People taking dopamine agonists to treat Parkinson's disease are at risk for impulse-control disorders such as compulsive gambling, buying and sexual ...
The U.S. Food and Drug Administration approved Nuplazid (pimavanserin) tablets last week as the first approved drug to treat hallucinations and delusions associated with psychosis experienced by some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results